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PI3K signaling is thought tomediate leptin and insulin
action in hypothalamic pro-opiomelanocortin
(POMC) and agouti-related protein (AgRP) neurons,
key regulators of energy homeostasis, through
largely unknown mechanisms. We inactivated either
p110a or p110b PI3K catalytic subunits in these
neurons and demonstrate a dominant role for the
latter in energy homeostasis regulation. In POMC
neurons, p110b inactivation prevented insulin- and
leptin-stimulated electrophysiological responses.
POMCp110b null mice exhibited central leptin resis-
tance, increased adiposity, and diet-inducedobesity.
In contrast, the response to leptin was not blocked in
p110a-deficient POMC neurons. Accordingly,
POMCp110a null mice displayed minimal energy
homeostasis abnormalities. Similarly, in AgRP
neurons, p110b had a more important role than
p110a. AgRPp110a null mice displayed normal
energyhomeostasis regulation,whereasAgRPp110b
null mice were lean, with increased leptin sensitivity
and resistance to diet-induced obesity. These results
demonstrate distinct metabolic roles for the p110a
and p110b isoforms of PI3K in hypothalamic energy
regulation.
INTRODUCTION
Increased understanding of the molecular and cellular mecha-
nisms that regulate whole-body energy homeostasis is needed
to gain insights into the pathophysiology of obesity and for the
development of effective treatments (Barsh et al., 2000; BarshCell Mand Schwartz, 2002; Morton et al., 2006). Hypothalamic arcuate
nucleus (ARC) pro-opiomelanocortin (POMC)-expressing neu-
rons, and agouti-related protein (AgRP)- and neuropeptide Y
(NPY)-expressing neurons sense peripheral and central signals
that reflect nutritional status responding to nutrients, anorexi-
genic peripheral hormones such as leptin and insulin, and cen-
trally derived neuropeptides and neurotransmitters (Barsh
et al., 2000; Barsh and Schwartz, 2002; Bewick et al., 2005;
Gropp et al., 2005; Luquet et al., 2005; Xu et al., 2005a; Choud-
hury et al., 2005; Claret et al., 2007; Morton et al., 2006; Smith
et al., 2007). Integration of these signals by POMC and AgRP/
NPY neurons regulates both their neuronal activity and the
expression and release of their cognate neuropeptides and other
neurotransmitters, which combine to control both short- and
long-term energy balance (Barsh et al., 2000; Barsh and
Schwartz, 2002).
In these neurons, the precise intracellular signaling
machinery upon which both leptin and insulin act is incom-
pletely defined. Recent attention has focused upon class IA
phosphoinositide 3-kinases (PI3Ks), which are acutely regu-
lated by extracellular stimuli and have pleiotropic roles in
cellular and organismal physiology (Vanhaesebroeck et al.,
2005). Class IA PI3K isoforms consist of a p110 catalytic
subunit (p110a, p110b, or p110d) constitutively bound to one
of five distinct p85 regulatory subunits (Vanhaesebroeck
et al., 2005). p110a and p110b are widely expressed, while
p110d is predominantly expressed in leucocytes (Vanhaese-
broeck et al., 2005). Class IA PI3Ks catalyze the synthesis of
the lipid second messenger phosphatidylinositol (3,4,5)-
triphosphate (PIP3), which engages downstream effectors
such as the protein kinase B (PKB) pathway (Shepherd et al.,
1998; Vanhaesebroeck et al., 2005).
Evidence has implicated class IA PI3Ks in hypothalamic func-
tion, suggesting that they are a point of signaling integration for
leptin and insulin action. Both hormones stimulate PI3K activity
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inhibition of PI3K activity using broad-spectrum PI3K inhibitors
blocks the electrophysiological effects of leptin and insulin on
POMC neurons and inhibits the acute effects of leptin upon
feeding and glucose homeostasis (Hill et al., 2008; Morton
et al., 2005). However, there are significant unanswered ques-
tions regarding the precise role of class IA PI3K isoforms in
the hypothalamic regulation of energy homeostasis. First, the
effects of specific long-term manipulation of hypothalamic
expression of the two major catalytic subunits, p110a and
p110b, on body weight regulation are not known. Recent phar-
macological evidence using isoform-specific PI3K inhibitors
and genetic studies using conditional p110a and p110b null
mice and cells have started to reveal specific roles for p110a
and p110b in peripheral tissues (Chaussade et al., 2007;
Ciraolo et al., 2008; Graupera et al., 2008; Jia et al., 2008; Knight
et al., 2006). Therefore, these molecules may have different
contributions to the regulation of neuronal function. The role of
PI3K signaling in AgRP neurons in the regulation of energy
homeostasis has also not been determined. In the context
of ongoing PI3K drug development, a key question is which
of the many PI3K isoforms should be targeted to achieve
specific therapeutic benefit (Marone et al., 2008; Wymann
et al., 2003). We therefore inactivated p110a and p110b in
Figure 1. Genetic Inactivation of p110a and
p110b in Hypothalami of POMCp110 Null
and AgRPp110 Null Mice
Recombination of p110a (A) or p110b (B) alleles in
the hypothalamus (H), but not the cerebral cortex
(C), of POMCp110null and AgRPp110 null mice.
Unaltered expression of p85 and reduction of
p110a activity (C) or p110b activity (D) in hypotha-
lamic lysates from POMCp110 null and AgRPp110
null mice, n = 3. All values are mean ± SEM,
*p < 0.05.
POMC or AgRP neurons to determine
the role of these kinases in energy
homeostasis.
RESULTS
Generation of Mice Lacking p110a
or p110b in POMC and AgRP
Neurons
Mice with floxed alleles of either p110a
(Pik3ca) or p110b (Pik3cb) (Graupera
et al., 2008; Guillermet-Guibert et al.,
2008) were crossed with mice that
express Cre recombinase in POMC or
AgRP neurons (Choudhury et al., 2005;
Claret et al., 2007; Xu et al., 2005a,
2005b) to generate POMCp110 null and
AgRPp110 null mice for each isoform
and relevant control strains. The floxed
alleles of p110a and p110b were de-
signed to preserve the signaling stoichi-
ometry of the p85/p110 PI3K signaling
complexes (Graupera et al., 2008; Guillermet-Guibert et al.,
2008). In the brain, genetic inactivation of p110a or p110b was
restricted to the hypothalamus, as determined by PCR analysis
of the recombination event (Figures 1A and 1B). We did not
detect Cre recombinase expression in the dentate gyrus or
nucleus tractus solitarus (data not shown). Hypothalamic
p110a lipid kinase activity in POMC- and AgRPp110a null mice
(Figure 1C) and p110b activity in POMC- and AgRPp110b null
mice (Figure 1D) was reduced, but expression of p85 was unal-
tered (Figures 1C and 1D). Expression of p110a, p110b, and p85
inmuscle, liver, and fat was also equivalent in mutant and control
mice (data not shown).
Inactivation of p110a or p110b in POMC and AgRP
Neurons Does Not Lead to Observable Alterations
in Cell Body Organization and Number
PI3K signaling plays key roles in cellular function, but mutant
mice did not show alterations in the location, population
size, or somatic dimensions of POMC (see Figures S1A–S1H
available online) or AgRP neurons (Figures S2A–S2H) compared
to control mice. No differences were observed in basic neu-
ronal biophysical properties in the mutant mice, although the
resting membrane potential of POMCp110a null neurons
was slightly hyperpolarized compared to control POMC344 Cell Metabolism 10, 343–354, November 4, 2009 ª2009 Elsevier Inc.
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However, this change in firing rate did not affect basal peptide
release, as hypothalamic explant studies showed that release
of alpha melanocyte-stimulating hormone (a-MSH) and AgRP
in POMC- and AgRP-targeted mutants, respectively, was equiv-
alent to control mice (Figures S3A–S3D). The POMC promoter
also drives Cre recombinase expression in anterior pituitary cor-
ticotrophs, but corticosterone levels in all four mutant lines were
equivalent to control mice (Figures S4A–S4D).
POMCp110b Null Mice Display Increased Food Intake,
Adiposity, and Sensitivity to a High-Fat Diet
POMCp110b null mice on standard chow displayed normal
total body mass but an increased fat mass and fasting hyper-
Figure 2. Energy Homeostasis Phenotypes
in POMCp110a Null and POMCp110b Null
Mice
Body weight curves of male POMCp110b null (A)
and POMCp110a null (B) mice on chow diet, n =
30 per genotype. (C) Fat pad mass in 40-week-
old POMCp110a null and POMCp110b null mice,
n = 10. (D) Fasting plasma leptin levels in control,
POMCp110a null, and POMCp110b null mice,
n = 8. (E) Twenty-four hour food intake under freely
feeding conditions in 12-week-old male control,
POMCp110a null and POMCp110b null mice,
n = 10–14. Food intake after overnight fast in
16-week-old male POMCp110a null (F) and
POMCp110b null (G) mice, n = 10–14. Bodyweight
(H), percentage fat mass (I), and fasting plasma
leptin levels (J) of POMCp110a null and
POMCp110b null mice following 18 week expo-
sure to HFD, n = 10–15. All values are mean ±
SEM, *p < 0.05.
leptinemia (Figures 2A, 2C, and 2D).
Magnetic resonance imaging (MRI) at
24 weeks of age confirmed increased
total body adiposity (fat mass per body
weight, POMCp110b null 16.2% ±
1.2% versus control 9.5% ± 1.3%, n = 5,
p < 0.01). POMCp110a null mice, in
contrast, displayed normal body weight,
fat mass, and leptin levels (Figures 2B–
2D). POMCp110b null mice, but not
POMCp110a null mice, displayed in-
creased food intake, both daily and
following an overnight fast (Figures 2E–
2G), and increased linear growth
(Figures S5A andS5B). Restingmetabolic
rate (RMR) and sensitivity to
the peripherally administered MC3/4R
agonist melanotan II (MT-II) were
normal in both POMCp110a null and
POMCp110b null mice (Figures S5C–
S5F). On a high-fat diet (HFD), both
POMCp110a null and POMCp110b null
mice displayed increased body weight,
adiposity, and hyperleptinemia, compared to controls (Figures
2H–2J).
AgRPp110b Null Mice Are Hypophagic, Lean,
and Resistant to Diet-Induced Obesity
Body weight (Figure 3A), fat mass (Figure 3C), and leptin levels
(Figure 3D) were significantly lower in AgRPp110b null mice.
Food intake ad libitum and following an overnight fast was
reduced in AgRPp110b null mice (Figures 3E and 3G). In contrast,
AgRPp110a null mice displayed no significant alterations within
these parameters (Figures 3B–3F). RMR and sensitivity to MT-II
were normal in both AgRPp110a null and AgRPp110b null
mice (Figures S6A–S6D). On HFD, AgRPp110b null, but not
AgRPp110a null, mice displayed a significant reduction in bodyCell Metabolism 10, 343–354, November 4, 2009 ª2009 Elsevier Inc. 345
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ures 3H–3J).
Leptin-Mediated Suppression of Food Intake Is Impaired
in POMCp110b Null Mice but Enhanced in AgRPp110b
Null Mice
In POMCp110b null mice, suppression of food intake by leptin
administered into the third cerebral ventricle (i.c.v.) was equiva-
lent to control mice at 4 hr but blunted at 24 hr postinjection
(Figure 4A). Conversely, AgRPp110b null mice had increased
sensitivity to i.c.v. leptin at both 4 and 24 hr postinjection,
compared to controls (Figure 4B). Inactivating p110a in POMC
or AgRP neurons did not affect the response to leptin (Figures
S7A and S7B).
Figure 3. Energy Homeostasis Phenotypes
in AgRPp110a Null and AgRPp110b Null
Mice
Body weight curves of male AgRPp110b null (A)
and AgRPp110a null (B) mice on chow diet, n = 30
per genotype. (C) Percentage fat pad mass in
40-week-old AgRPp110a null and AgRPp110b
null mice, n = 10. (D) Fasting plasma leptin levels
in AgRPp110a null and AgRPp110b null mice,
n = 8. (E) Twenty-four hour food intake under
freely feeding conditions in 12-week-old male
AgRPp110a null and AgRPp110b null mice,
n = 10–14. Food intake after overnight fast in
16-week-old male AgRPp110a null (F) and
AgRPp110b null (G) mice, n = 10–12. Body weight
(H), percentage fat mass (I), and fasting plasma
leptin levels (J) of AgRPp110a null and
AgRPp110b null mice following 18 week exposure
to HFD, n = 10–15. All values are mean ± SEM,
*p < 0.05, **p < 0.01, ***p < 0.001.
Hypothalamic Neuropeptide
mRNA Expression and Glucose
Homeostasis in p110 Mutant Mice
A small but significant reduction in Pomc
mRNA was detectable in fasted
POMCp110b null mice, while Agrp and
Npy mRNA were unaltered (Figure 4C).
Npy mRNA was reduced in AgRPp110b
null mice, while Pomc and Agrp mRNA
were unchanged (Figure 4D). No differ-
ences in the expression of Pomc, Agrp,
and Npy mRNA were detected in
POMCp110a null and AgRPp110a null
mice (Figures S7C and S7D). Leptin also
recruits the janus kinase/signal trans-
ducer and activator of transcription
(JAK/STAT) pathway to modulate the
expression of arcuate neuropeptides.
However, we found no alteration of lep-
tin-stimulated STAT3 phosphorylation in
POMC or AgRP neurons lacking p110b
(percent leptin-stimulated POMC or
AgRP neuron pSTAT3: control, 46% ±
6% versus POMC p110b null, 42% ±
5%, p = N.S.; control 54% ± 5% versus AgRP p110b null
67% ± 9% p = N.S., n = 3 animals per genotype and Figure S8).
POMC and AgRP neurons have been implicated in the central
regulation of glucose homeostasis (Konner et al., 2007; Parton
et al., 2007), but no alterations were found in fasting glucose
levels, glucose tolerance, and fasting insulin levels in all four
mutant lines (Figures S9A–S9H).
p110b Is Required for Leptin-Induced Depolarization
of POMC Neurons
We next used electrophysiological analysis to investigate
neuronal responses to leptin and insulin in POMCp110b null
and POMCp110a null mice. Consistent with previous observa-
tions (Choudhury et al., 2005; Claret et al., 2007; Cowley et al.,346 Cell Metabolism 10, 343–354, November 4, 2009 ª2009 Elsevier Inc.
Cell Metabolism
Hypothalamic p110b Regulates Energy Homeostasis2001; Plum et al., 2006), a subpopulation of control POMC
neurons (6 of 21) responded to locally applied leptin (50 nM) by
long-lasting (>1 hr) membrane depolarization (Figure 5A), an
action significant for the recorded population (n = 21, p < 0.05;
Table 1). Although leptin depolarization of POMC neurons could
be observed at resting membrane potentials (Vm) of approxi-
mately 50 mV, the magnitude of response was greater at
more hyperpolarized Vm (r2 = 0.63, n = 21, p < 0.0001;
Figure S10A). As previously reported, the majority of control
POMC neurons were unresponsive to leptin (Table 1 and
Figure S10B).
As POMCp110b null mice displayed reduced sensitivity to lep-
tin, we examined the effect of genetic inactivation of specific
PI3K catalytic subunit isoforms on leptin-mediated POMC excit-
ability. In mice aged 8–16 weeks, leptin depolarized (n = 13,
p < 0.05) the POMCp110a null neuronal population and
increased their spike firing frequency (Figure 5B and Table 1),
in agreement with the unchanged leptin sensitivity observed
in vivo. In contrast, leptin did not depolarize POMCp110b null
neurons, and indeed many POMCp110b null neurons (7 of 17)
exhibited long-lasting hyperpolarization following leptin applica-
tion (Figure 5C, Table 1). Subsequently, in a separate series of
experiments on age- (7- and 18-week-old) and sex-matched
POMCp110b null mutant mice, we first showed that food intake
was elevated at both 7 and 18 weeks of age. Irrespective of age
or metabolic phenotype, subsequent electrophysiological re-
cordings from POMCp110b null neurons demonstrated that
there were no alterations to POMC neuron resting membrane
potential, spike firing frequency, or input resistance in compar-
ison to littermate control POMC neurons (Table S2). Further-
more, these POMCp110b null neurons exhibited the same
Figure 4. Response to Centrally Adminis-
tered Leptin and Hypothalamic Neuropep-
tide Expression of POMCp110b Null and
AgRPp110b Null Mice
Suppression of food intake in POMCp110b null (A)
and AgRPp110b null (B) mice following i.c.v. injec-
tion of leptin (0.5 mg), n = 8. Pomc, Agrp, and Npy
mRNA expression in hypothalami of POMCp110b
null (C) and AgRPp110b null (D) mice. All values are
mean ± SEM, *p < 0.05, ***p < 0.001.
altered response to leptin (i.e., conver-
sion of depolarization to hyperpolariza-
tion) that was significantly different from
the leptin-mediated excitation of control
POMC neurons.
To exclude the possibility that
compensatory changes associated with
chronic ablation of p110b expression
were responsible for this altered leptin
response, in separate experiments on
control POMC neurons, the selective
p110b inhibitor TGX-221 (1 mM) (Jackson
et al., 2005) was added to the internal
pipette solution. Following a minimum of
10 min of intracellular dialysis, leptin
(50 nM) application did not excite TGX-
221-treated POMC neurons (n = 11, N.S.; Figure 5D and Table 1).
On one occasion, a large leptin-mediated hyperpolarization
was observed, which was reversibly occluded by bath-applied
tolbutamide, indicating the likely involvement of ATP-sensitive
K+ (KATP) channels in this hyperpolarizing response (Fig-
ure S10C). Overall, these electrophysiological outcomes reflect
the decreased leptin sensitivity found in POMCp110b null mice
in vivo.
Inactivation of p110a or p110b in POMC Neurons
Prevents Insulin-Induced Hyperpolarization
POMC neurons are also targets for insulin action, and consistent
with previous reports (Choudhury et al., 2005; Claret et al., 2007;
Hill et al., 2008; Konner et al., 2007; Plum et al., 2007), a subpop-
ulation of control POMC neurons (12 of 19) responded to insulin
by long-lasting (>1 hr) hyperpolarization (Table 1 and Figure 5E).
Subsequent bath application of tolbutamide (200 mM) reversed
this response (Figure 5E). The remaining neurons were unre-
sponsive to insulin (50 nM, Figure S10D). Neither POMCp110a
null (n = 8, N.S.; Figure 5F) nor POMCp110b null (n = 9, N.S.;
Figure 5G) neurons responded to insulin (Table 1), suggesting
that both p110 isoforms contribute to the action of insulin in
POMC neurons. Acute pharmacological inhibition of p110b by
TGX-221 (1 mM) also prevented insulin hyperpolarization of
POMC neurons (n = 8, N.S.; Figure 5H and Table 1). In addition,
the pan-PI3K/mTOR inhibitor, PI-103 (100 nM), prevented
insulin-evoked POMC neuron hyperpolarization (n = 7;
Figure 5I and Table 1).
Thus, leptin and insulin induce opposing electrical responses
in subsets of POMC neurons, and both outcomes require the
p110b subunit of PI3K. This result could be due to differentialCell Metabolism 10, 343–354, November 4, 2009 ª2009 Elsevier Inc. 347
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p110b subunits in the POMC neuron population. We attempted
to resolve this issue in two ways, by electrophysiological anal-
ysis of the actions of sequentially applied leptin and insulin to
single POMC neurons and by immunohistochemical detection
of POMC neurons in mice expressing lacZ from either the
p110a or the p110b loci. Sequential leptin- and insulin-induced
depolarization and hyperpolarization, respectively, were ob-
served in three of eight recordings, indicating functional coloc-
alization of receptors in a subpopulation of POMC neurons
(Figure 5J and Figure S11A). However, some POMC neurons
only responded to leptin (two of eight), with the remainder
(three of eight) not responding to either hormone. Note that
we did not observe POMC neurons that only responded to
insulin. Furthermore, 47% (±4.3, n = 3) of POMC neurons
Figure 5. PI3K Activity Underlies Leptin and
Insulin Modulation of POMC Neuronal
Excitability
Whole-cell recordings were made from control
(A, D, E, H, I, and J), p110a null (B and F), and
p110b null (C and G) POMC neurons. Contin-
uous current-clamp traces are shown in upper
traces and expanded sections in lower traces,
respectively. A minority population of control
(A) and p110a null (B) POMC neurons were de-
polarized by leptin (50 nM for 2 min, as indicated
by the arrows), which was associated with an
increase in spike firing frequency (upward
deflections). Leptin hyperpolarized a minority
population of p110b null (C) but had no effect
on the majority of p110b-inhibited (1 mM
TGX-221) (D) POMC neurons. (E) Insulin (50 nM
for 2 min, where indicated) hyperpolarized the
majority of POMC neurons, which was reversed
by the subsequent application of 200 mM tolbu-
tamide. Note that there was a small reduction
in input resistance following insulin application,
as denoted by the reduced amplitude of the
periodic downward deflections shown in the
continuous trace. Genetic inactivation of p110a
(F) or p110b (G) prevented insulin modulation of
POMC neuron excitability. Pharmacological inhi-
bition of p110b (1 mM TGX-221) (H) or a general
PI3K inhibitor (100 nM PI-103) (I) prevented
insulin modulation of POMC neuronal excitability.
(J) Representative continuous current-clamp
trace before and after sequential leptin and
insulin (50 nM for 2 min) application as indicated
by the arrows. Expanded sections are shown
underneath at time points indicated by the
corresponding letters in italics. Note that leptin-
induced depolarization was reversed by subse-
quent insulin application, although a subsequent
leptin administration had no effect on membrane
potential.
expressed p110b and 55% (±5.7, n = 3)
p110a (Figures S11B and S11C). Ac-
cordingly, some POMC neurons must
express both hormone receptors and
p110 subunits, whereas the expression
of p110b alone may explain why some POMC neurons respond
only to leptin.
p110a and p110b Are Required for Insulin-Induced
Depolarization of AgRP Neurons
Consistent with our previous data (Claret et al., 2007), leptin
(50 nM) did not affect Vm or spike frequency in control AgRP
(n = 7, N.S., Table 1, Figure 6A), or AgRPp110a null (n = 7,
N.S.; Table 1, Figure 6B), or AgRPp110b null (n = 7, N.S.; Table 1,
Figure 6C) neurons. In contrast, insulin (50 nM) caused a long-
lasting (>1 hr) depolarization of a subpopulation (4 of 13) of
control AgRP neurons (Figure 6D), an action significant for the re-
corded population (n = 13, p < 0.05; Table 1). As observed for
leptin on POMC neurons, the depolarization induced by insulin
was greater at more hyperpolarized Vm (r2 = 0.65, p < 0.0001,348 Cell Metabolism 10, 343–354, November 4, 2009 ª2009 Elsevier Inc.
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Total Responsive
DVm (mV) D Spike (Hz) DVm (mV) D Spike (Hz)
+Leptin
POMC +1.3 ± 0.6* (21) +0.5 ± 0.3 (21) +4.5 ± 1.3 (6/21) +1.6 ± 0.4 (6/21)
POMCp110a null +3.2 ± 1.4* (13) +1.0 ± 0.5* (13) +6.3 ± 1.9 (7/13) +2.2 ± 0.5 (7/13)
POMCp110b null 2.1 ± 1.1 (17) +0.1 ± 0.4 (17) 6.1 ± 1.7 (7/17) 1.2 ± 0.5 (7/17)
POMC + TGX-221 0.9 ± 1.6 (11) +0.3 ± 0.8 (11) 16.0 (1/11) 5.6 (1/11)
AgRP 0.1 ± 1.1 (7) 0.5 ± 0.8 (7) N.R. N.R.
AgRPp110a null 1.2 ± 0.9 (7) 0.9 ± 0.4 (7) N.R. N.R.
AgRPp110b null 0.0 ± 0.2 (7) 0.3 ± 0.4 (7) N.R. N.R.
+Insulin
POMC 4.4 ± 1.1* (19) 2.2 ± 0.7* (19) 7.1 ± 1.1 (12/19) 3.4 ± 0.9 (12/19)
POMCp110a null 0.6 ± 0.3 (8) 0.2 ± 0.2 (8) N.R. N.R.
POMCp110b null +0.4 ± 0.9 (9) +1.0 ± 0.6 (9) N.R. N.R.
POMC +TGX-221 +0.9 ± 0.6 (8) 0.1 ± 0.2 (8) N.R. N.R.
POMC + PI-103 +1.1 ± 0.7 (7) +0.3 ± 0.6 (7) N.R. N.R.
AgRP +1.4 ± 0.5* (13) +0.5 ± 0.3 (13) +3.8 ± 0.9 (4/13) +0.9 ± 0.3 (4/13)
AgRPp110a null 4.0 ± 0.6* (7) 1.9 ± 0.9 (7) 4.0 ± 0.6 (7/7) 1.9 ± 0.9 (7/7)
AgRPp110b null 2.7 ± 1.1* (11) 0.4 ± 0.3 (11) 5.2 ± 1.4 (6/11) 0.6 ± 0.4 (6/11)
AgRP + wortmannin 2.0 ± 0.8* (10) 0.4 ± 0.3 (10) 4.2 ± 0.8 (5/10) 1.1 ± 0.3 (5/10)
Changes in membrane potential (Vm) and spike firing frequency are shown for control, p110a, or p110b null POMC and AgRP neurons. PI3K activity
was also blocked in POMC and AgRP neurons by PI-103 (100 nM), wortmannin (100 nM), or the p110b-selective inhibitor TGX-221 (1 mM). Statistical
significance (*p < 0.05) was determined from all neurons (Total), irrespective of their response. For qualitative purposes only, responsive neurons were
distinguished by a change in Vm greater than ±2 mV. N.R., no apparent response. Numbers of cells are shown in parentheses. Data are expressed as
mean ± SEM.n = 13, Figure S12A). Insulin did not change the excitability of the
remaining AgRP neurons (recording periods up to 1 hr;
Figure S12B). We next tested whether inactivation of p110a or
p110b prevented or modified insulin action on AgRP neurons.
Surprisingly, insulin hyperpolarized both AgRPp110a null (n = 7,
p < 0.05; Figure 6E) and AgRPp110b null (n = 11, p < 0.05;
Figure 6F) neurons, and these responses were reversed by
tolbutamide. In addition, the pan-PI3K inhibitor wortmannin
(100 nM present in the internal recording solution), although
having no effect per se on Vm, also resulted in insulin hyperpola-
rizing control AgRP neurons (n = 10, p < 0.05; Table 1),
a response occluded, reversibly, by tolbutamide (Figure 6G).
DISCUSSION
Hypothalamic PI3K signaling mechanisms have received signif-
icant attention and may act as a point of convergence for leptin
and insulin action in POMCandAgRP neurons. However, studies
to date have indirectly used genetics to manipulate PI3K sig-
naling or have used inhibitors such as wortmannin and
LY294002, which inhibit all PI3K isoforms and several other
kinases such as mTOR, which has also been implicated in hypo-
thalamic function. Both strategies also do not enable discrimina-
tion between the distinct PI3K isoforms. Using newly created
floxed alleles of p110a and p110b, which preserve the stoichi-
ometry of the class IA PI3K signaling network (Graupera et al.,
2008; Guillermet-Guibert et al., 2008), our study reveals a domi-
nant role for p110b in POMC and AgRP neurons.Cell MOur studies (summarized in Table S3) show that POMCp110b
null mice display hyperphagia, increased adiposity, and hyper-
leptinemia on normal chow diet and increased sensitivity to
high-fat feeding. Furthermore, POMC neurons, in which p110b
was genetically or pharmacologically inhibited, were electrically
unresponsive to insulin and leptin. Indeed, the inability of leptin to
excite POMCp110b null neurons (and instead hyperpolarize
them) was correlated with elevated food intake in POMCp110b
null mice, which was also not fully suppressed by centrally
administered leptin. POMCp110b null mice had a reduction in
POMC mRNA levels consistent with reports suggesting that
the modulation of POMC transcription by leptin is dependent
on PI3K-controlled regulation of forkhead box O1 (FoxO1)
activity (Kim et al., 2006; Kitamura et al., 2006). Thus, inactivation
of p110b in POMC neurons may result in an overall reduction in
the expression and release of a-MSH, which may make these
mice more likely to store excess energy as fat on a standard
chow diet and more susceptible to weight gain when exposed
to a HFD. In contrast, POMCp110a null mice did not display a
significant body weight phenotype under standard chow condi-
tions but did develop increased adiposity and hyperleptinemia
when exposed to a HFD, indicating an as yet undefined role for
POMCp110a in response to excess caloric intake. Genetic inac-
tivation of p110a prevented insulin-induced hyperpolarization,
although it did not prevent leptin-mediated depolarization of
POMC neurons. The precise roles of insulin action on this
neuronal type have not been fully elucidated, but as deletion of
the insulin receptor on POMC neurons is not reported to causeetabolism 10, 343–354, November 4, 2009 ª2009 Elsevier Inc. 349
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type in POMCp110a mice is consistent with this observation.
Blockade of insulin-induced hyperpolarization in POMC neurons
may therefore not translate to abnormalities in metabolism.
Previous mouse genetic evidence has also linked PI3K
signaling in POMC neurons with the regulation of energy homeo-
stasis. However, due to the nature of the various approaches,
there has been some discordance in the results. For example,
PIP3 production was elevated in POMC neurons in which the
phosphatase and tensin homolog (Pten), a PIP3 phosphatase,
was specifically deleted, and these mice were hyperphagic
and displayed diet-sensitive obesity (Plum et al., 2006). Mice
harboring combined POMC-selective deletion of p85a with a
global deletion of p85b subunit were unresponsive to insulin
and leptin in electrophysiological studies (Hill et al., 2008). These
mice had abnormalities in both short-term feeding and acute
responses to leptin but had no long-term disorder in energy
homeostasis. However, POMC-specific deletion of Pten or p85
is likely to have effects beyond PI3K signaling. Deletion of Pten
Figure 6. Insulin-Induced Depolarization
of AgRP Neurons Is Dependent on p110a
and p110b Expression
Leptin (50 nM) does not modulate the excitability
of control (A) and p110a (B) or p110b (C) null
AgRP neurons. (D) A minority population of AgRP
neurons were depolarized by insulin (50 nM), and
this was associated with an increase in spike firing
frequency. A proportion of p110a (E) and p110b (F)
null or PI3K-inhibited (100 nM wortmannin; G)
AgRP neurons were hyperpolarized by insulin,
and this effect was reversibly occluded by
200 mM tolbutamide.
has a profound anatomical impact on
POMC neurons, and the role of both
Pten’s lipid phosphatase (i.e., PI3K-
dependent) and protein phosphatase
activities in regulating leptin action
suggest that this model may have addi-
tional abnormalities (Ning et al., 2006;
Plum et al., 2006). Deletion of the p85
regulatory subunits often leads to in-
creased PI3K signaling (Vanhaesebroeck
et al., 2005). For example, the p85b global
null mouse has improved insulin and
potentially leptin action and is smaller
than control littermates (Ueki et al.,
2002). Furthermore, tyrosine phosphory-
lation of IRS2 is upregulated in these
mice, which may impact upon long-term
energy balance. p85a and p85b subunits
also have signaling roles independent
of their association with p110 catalytic
subunits, and therefore full deletion of
p85 subunits may lead to effects inde-
pendent of PI3K catalytic activity (Okken-
haug and Vanhaesebroeck, 2001).
Like POMC neurons, AgRP neurons
are targets for leptin and insulin action,
but the role of PI3K in these neurons is largely unknown. Mice
in which p110b, but not p110a, was inactivated in AgRP neurons
display an age-dependent lean phenotype with reduced
adiposity, hypoleptinemia, and resistance to diet-induced ob-
esity (Table S3). This phenotype may be surprising, given that
disruption of leptin receptor expression specifically in AgRP
neurons results in mild obesity, suggesting that loss of leptin
action via PI3K signaling might result in a similar phenotype.
However, leptin withdrawal, rather than administration, has
been described to activate PI3K and accumulate PIP3 in AgRP
neurons (Xu et al., 2005b). Thus reducing PI3K activity in AgRP
neuronsmay result in these cells behaving as if they are exposed
to increased leptin levels, physiologically resulting in a lean
phenotype (Xu et al., 2005b). However, consistent with our
previous study (Claret et al., 2007), leptin did not change the
excitability of control and p110a or p110b null AgRP neurons.
Although others have observed leptin-mediated hyperpolariza-
tion of a subpopulation of rat AgRP-expressing neurons (van
den Top et al., 2004), methodological and species differences350 Cell Metabolism 10, 343–354, November 4, 2009 ª2009 Elsevier Inc.
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AgRP neurons under our recording conditions (Claret et al.,
2007), but in p110b- or p110a-deleted as well as pharmacolog-
ically PI3K-inhibited AgRP neurons, insulin inhibits the excit-
ability of these neurons. The net effect of this alteration would
be to reduce insulin-induced depolarization and consequently
decrease the release of AgRP and NPY with a resultant attenua-
tion in orexigenic output. Mice lacking either Agrp or Npy have
mild body weight phenotypes or reduced feeding after a fast
(Patel et al., 2006; Wortley et al., 2005). NpymRNA was reduced
in the hypothalamus of AgRPp110b null mice, therefore poten-
tially contributing to the lean phenotype observed in these
mice.STAT3signaling is reported toplay amajor role inmediating
leptin-induced alteration in neuropeptide expression including
Agrp and Npy. However, leptin-stimulated STAT3 phosphoryla-
tion was equivalent in both AgRP and AgRPp110b null neurons
and is unlikely to underlie the lean phenotype in these mice.
An important issue arising from the electrophysiological
studies pertains to the mechanisms by which leptin and insulin,
through the increased production of a signaling molecule in
common (i.e., PIP3), produce opposing electrical responses in
POMC neurons. Approximately half of POMC neurons express
p110a or p110b. However, due to the lack of suitable reagents,
we have not been able to establish the coincidence of expression
of these subunits in POMC neurons. The finding that leptin, but
not insulin, alone can modify electrical activity of some POMC
neurons could be explained either by selective expression of
the p110b subunit alone or the leptin receptor exhibiting selec-
tive coupling to this subunit. In contrast, it is less likely that
p110a is expressed in a subpopulation of POMC neurons inde-
pendently from p110b, as insulin responses were only observed
in neurons that also responded to leptin and insulin-mediated
POMC neuron hyperpolarization required the presence of both
p110 subunits. The inability of both leptin and insulin to modulate
the electrical activity of some POMC neurons may indicate that
they lack functional receptors for either hormone (Cheung
et al., 1997; Elias et al., 1999; Huo et al., 2009). Alternatively,
these unresponsive POMC neurons may lack the p110b subunit,
although we have no way of determining whether the p110a
subunit is present or not in these neurons. The finding that
insulin-mediated hyperpolarization of POMC, and depolarization
of AgRP, neurons was ablated by removal of either p110a or
p110b may indicate that both catalytic subunits are required to
generate sufficient PIP3 to pass some threshold level for down-
stream signaling. Such a scenario has been proposed previously
whereby p110b activity serves to set the threshold for p110a
activation (Ciraolo et al., 2008; Jia et al., 2008; Knight et al.,
2006). Nevertheless, there must be divergent downstream
signaling pathways activated following a rise in PIP3 to explain
the opposing PI3K-dependent electrical responses seen in
some POMC neurons to leptin and insulin, which results in either
KATP channel activation (hyperpolarization) or the activation of
an, as yet, ill-defined putative nonselective cation channel
(depolarization). The insulin-mediated hyperpolarization of
AgRP neurons observed on genetic deletion of either p110 sub-
unit, or by pharmacological inhibition of PI3K activity, indicates
the presence of a separate, possibly PIP3-independent, path-
way leading to activation of KATP channels that is normally
occluded by PI3K signaling in these neurons.Cell MRecent studies have begun to link different physiological prop-
erties with the various PI3K catalytic subunit isoforms (Shaywitz
et al., 2008). For example, we have demonstrated that p110a,
and not p110b, plays a key role in developmental angiogenesis
(Graupera et al., 2008) and have provided evidence that p110b
lies downstream of G protein-coupled receptors (GPCRs) in
fibroblasts and macrophages and is not acutely regulated by
receptor tyrosine kinases (Guillermet-Guibert et al., 2008).
p110a appears to predominantly mediate the effects of insulin
and other receptor tyrosine kinases in some tissues, although
here we show that p110b is equally important for insulin-medi-
ated changes in electrical excitability of hypothalamic neurons.
At present, it is unknown which isoform is responsible for lep-
tin-mediated PI3K actions in tissues, although in this study
p110b plays the principal role in POMC neurons. Recently it
has been demonstrated that liver-specific deletion of p110b
abrogates insulin action in this tissue (Jia et al., 2008). Interest-
ingly, these mice also displayed hyperleptinemia and dysregula-
tion of key hepatic metabolic genes (Jia et al., 2008). Further-
more, these studies suggested that p110b lipid kinase activity
is not able to direct PKB phosphorylation but plays a role in S6
kinase-1 activation (Jia et al., 2008), an event that has recently
been implicated in hypothalamic regulation of energy homeo-
stasis (Woods et al., 2008). The predominance of p110b sig-
naling, perhaps recruited by GPCRs rather than by IRS2-associ-
ated p110a signaling, in POMC and AgRP neurons is consistent
with our findings that mice lacking Irs2 in these cell types have no
energy homeostasis phenotype (Choudhury et al., 2005). It is
also possible that p110b is playing a scaffolding role in signaling
(Ciraolo et al., 2008; Jia et al., 2008) in POMC and AgRP neurons
and that this may mediate some of the observed effects of
deleting this molecule in these neurons. These considerations
may also underlie the ability of PI3K to mediate opposing
responses to leptin and insulin in POMC neurons and affect an
entirely opposite outcome with respect to excitability observed
on the loss or inhibition of one of the isoforms. Furthermore, if
these PI3K isoforms are capable of being modulated indepen-
dently by extrinsic factors, this may profoundly affect the cellular
outcome to leptin and insulin and have a major impact on energy
homeostasis.
In summary, our studies have revealed an isoform-specific
role for class IA PI3K signaling in POMC neurons and demon-
strate for the first time the key role of class IA PI3K signaling in
AgRP neurons in the long-term regulation of energy homeo-
stasis.
EXPERIMENTAL PROCEDURES
Mice and Animal Care
The generation and genotyping of POMC-Cre and AgRP-Cre (Choudhury
et al., 2005; Claret et al., 2007; Xu et al., 2005a, 2005b), Pik3caflox or p110aflox
(Graupera et al., 2008), and Pik3cbflox or p110bflox (Guillermet-Guibert et al.,
2008) mice have been previously described. Mice with floxed alleles were in-
tercrossed with the indicated Cre-expressing transgenic mice to generate
compound heterozygote mice. These double heterozygote mice were then in-
tercrossed with lox+/mice to obtain WT, flox+/+, Cre, and Cre/flox+/+ mice for
each line. To generatemice lacking floxed alleles but expressing GFP or YFP in
cells harboring the deletion event, mice were intercrossed with Z/EG (Novak
et al., 2000) or Rosa26YFP (Srinivas et al., 2001) indicator mice and bred to
homozygosity for the floxed allele. For detection of Cre-mediated excision of
exons 18 and 19 of p110a in the hypothalami of AgRPp110a null andetabolism 10, 343–354, November 4, 2009 ª2009 Elsevier Inc. 351
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cortex, and other tissues of control and mutant mice as previously described
(Choudhury et al., 2005). The generation of a 544 bp DNA product following
PCR with primers ACACACTGCATCAATGGC and GCTGCCGAATTGCTAGG
TAAGC is indicative of excision of the floxed p110a exons in AgRP and
POMC neurons of AgRPp110a null and POMCp110a null mice, respectively.
For detection of Cre-mediated excision of exons 21 and 22 of the p110b cata-
lytic domain in the hypothalami of AgRPp110b null and POMCp110b null mice,
mRNA was extracted from the hypothalamus and cortex of control andmutant
mice and transcribed into cDNA as previously described (Choudhury et al.,
2005). Resulting cDNA was used as a template for PCR to amplify exons
19–23 using primers located in exon 19 (TTGGACCTGCGGATGCTCCCCTAT)
and exon 23 (CGCATCTTCACAGCACTGGCGGA). The generation of a
204 bp PCR fragment in hypothalamic samples from AgRPp110b null and
POMCp110b null mice indicated successful splicing of exon 20 onto exon
23, resulting in the generation of an internally truncated p110b protein in these
neuronal populations. All knockout and transgenic mice were studied with
appropriate littermates of the three control genotypes in all studies. We did
not detect any sexual dimorphism in the observed phenotypes. Any mouse
that tested positive for deletion in tail tissue due to potential germline recom-
bination of the floxed alleles was excluded from all studies. Mice were main-
tained on a 12 hr light/dark cycle with free access to water and standard
mouse chow (4% fat, RM1, Special Diet Services) and housed in specific path-
ogen-free barrier facilities. Mice were handled and all in vivo studies performed
in accordance to the United Kingdom Animals (Scientific Procedures) Act
(1986).
Metabolic Studies
Body weight and fat measurement, feeding, and HFD studies were performed
as previously described (Choudhury et al., 2005; Claret et al., 2007). Plasma
leptin and insulin levels were determined using mouse ELISAs (Linco Inc.).
MRI scanning was performed as previously described (Choudhury et al.,
2005).
I.c.v. Leptin Treatment
Stainless steel cannulae were inserted into the third ventricle (midline 0 mm,
0.82 mm posterior from bregma, depth 4.8 mm from skull surface) of mice
anaesthetizedwith isoflurane. Postsurgery,micewere singly housed and given
at least a week to recover to their presurgery weight. Correct cannula place-
ment was confirmed by demonstration of increased drinking after i.c.v. admin-
istration of angiotensin (10 ng). For i.c.v. leptin studies, food was removed from
mice 4 hr prior to the onset of the dark phase, and a bolus i.c.v. injection of
leptin (0.5 mg) or artificial cerebrospinal fluid (aCSF) was administered. Mice
were returned to their home cages immediately after injection. Prior to the
onset of dark phase, food was returned and food intake measured at 4 and
24 hr postinjection. All injections were done with an internal cannula projecting
0.5 mm below the tip of the cannula.
Quantitative RT-PCR Analysis
Quantitative RT-PCR was performed as previously described (Claret et al.,
2007). Proprietary sequence Taqman Gene Expression assay FAM/TAMRA
primers (Applied Biosystems, Foster City, CA, USA) were used: Agrp
(Mm00475829_g1), Hprt (Mm00446968_m1), Npy (Mm00445771_m1), and
Pomc (Mm00435874_m1).
Lipid Kinase Assays
PI3K activity assays on hypothalamic lysates were performed as previously
described (Bilancio et al., 2006).
Electrophysiology
Hypothalamic coronal slices (350 mm) were cut from 6- to 18-week-old trans-
genicmice expressing POMCCreZ/EG or AgRPCreRosa26YFPwith or without
p110a or p110b mutant alleles. Slices were maintained at room temperature
(22C–25C) in an external solution containing (in mM) NaCl 125, KCl 2.5,
NaH2PO4 1.25, NaHCO3 25, CaCl2 2, MgCl2 1, D-glucose 10, and D-mannitol
15 equilibrated with 95%O2, 5%CO2 (pH 7.4). POMC and AgRP neurons were
visualized in the ARC by the expression and excitation of GFP and YFP,
respectively. Whole-cell current-clamp (Ifast) recordings were made at 35C352 Cell Metabolism 10, 343–354, November 4, 2009 ª2009 Elsevierusing borosilicate glass pipettes (4–8 MU) containing (in mM) Kgluconate 130,
KCl 10, EGTA 0.5, NaCl 1, CaCl2 0.28, MgCl2 3, Na2ATP 3, GTP 0.3, phospho-
creatine 14, and HEPES 10 (pH 7.2), as previously described (Choudhury et al.,
2005; Claret et al., 2007; Smith et al., 2007). Following a minimum of 10 min of
stable recording, hormones were applied for 2–3 min using a broken tipped
pipette (3 mm) positioned above the recording neuron. Stock reagents
were diluted (R1000-fold) in a modified external solution with NaHCO3
replaced with HEPES (10 mM, pH 7.4). Stocks of recombinant leptin (R&D
Systems), insulin (Novo-Nordisk Inc.), TGX-221 (Cayman Chemical Inc.), and
wortmannin (Calbiochem Inc.) were diluted in HEPES-buffered external or
internal solutions. All other reagents were purchased from Sigma-Aldrich.
Statistical Analysis
Data are expressed as mean ± SEM. P values were calculated using nonpara-
metric (Mann-Whitney U test) and parametric (unpaired and paired t tests)
tests, performed as appropriate. P values%0.05 were considered statistically
significant. Statistical significance was calculated from all recordings (respon-
sive and nonresponsive) using a Student’s two-tailed paired t test or ANOVA,
followed by Bonferroni’s post hoc test where appropriate.
Additional experimental procedures are presented in the Supplemental
Data.
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